/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122903-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC BMT Etanercept For GVHD Ver 11-20-17 (HL 5772)

CSC SC BMT Etanercept For GVHD Ver 11-20-17 (HL 5772) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC BMT ETANERCEPT FOR GVHD VER: 11-20-17 –  Properties
Cycle 1 –  11/21/2017 through 12/18/2017 (28 days), Planned
Day 1, Cycle 1 –  Planned for 11/21/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Treatment Conditions
Treatment Condition A
Provide patient with Medication Guide. See Reference Links in navigator for hyperlink.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 4, Cycle 1 –  Planned for 11/24/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 8, Cycle 1 –  Planned for 11/28/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 11, Cycle 1 –  Planned for 12/1/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:23:22 AM Page 1 of 3
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 15, Cycle 1 –  Planned for 12/5/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 18, Cycle 1 –  Planned for 12/8/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 22, Cycle 1 –  Planned for 12/12/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 25, Cycle 1 –  Planned for 12/15/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:23:22 AM Page 2 of 3
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

Cycle 2 –  12/19/2017 through 1/15/2018 (28 days), Planned
Day 1, Cycle 2 –  Planned for 12/19/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 8, Cycle 2 –  Planned for 12/26/2017
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 15, Cycle 2 –  Planned for 1/2/2018
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Day 22, Cycle 2 –  Planned for 1/9/2018
Treatment Plan Information
Note to All Staff (1)
This Supportive Care protocol is intended for use in treatment of Graft Versus Host Disease (GVHD) in allogeneic stem
cell transplant patients. Refer to Acute Graft Versus Host Disease - Adult/Pediatric - Inpatient/Ambulatory Clinical
Practice Guideline. See Reference Links in navigator for hyperlink to UConnect location.
Supportive Care Medications
etanercept (ENBREL) 25 MG/0.5ML soln prefilled syringe 25 mg
25 mg, Subcutaneous, ONCE, 1 dose Starting when released
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:23:22 AM Page 3 of 3
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org